News - lasmiditan

Filter

Current filters:

lasmiditan

Popular Filters

Migraine drug sales to grow to $5.8 billion in 2021 in major markets

18-11-2012

Despite a decline in sales owing to the generic entry of most triptans, the launch of emerging acute…

AllerganBotoxCoLucidGenericsGloballasmiditanLevadexMAP PharmaceuticalsMarkets & MarketingPharmaceuticalResearch

Back to top